157 related articles for article (PubMed ID: 26620456)
1. The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men.
Teoh JY; Yuen SK; Tsu JH; Wong CK; Ho BS; Ng AT; Ma WK; Ho KL; Yiu MK
Asian J Androl; 2017; 19(1):113-116. PubMed ID: 26620456
[TBL] [Abstract][Full Text] [Related]
2. The use of prostate specific antigen density to predict clinically significant prostate cancer.
Yusim I; Krenawi M; Mazor E; Novack V; Mabjeesh NJ
Sci Rep; 2020 Nov; 10(1):20015. PubMed ID: 33203873
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Cutoff Point Prostate Specific Antigen (PSA) and Prostate Specific Antigen Density (PSAD) in Patients with Suspected Prostate Cancer.
Daryanto B; Trianto R; Seputra KP; Purnomo AF
Med Arch; 2024; 78(1):12-15. PubMed ID: 38481588
[TBL] [Abstract][Full Text] [Related]
4. The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density.
Chen Y; Jiang X; Liu R; Zhang Z; Luo F; Qi S; Xu Y
Med Sci Monit; 2019 Aug; 25():6230-6235. PubMed ID: 31424055
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes.
MacAskill F; Lee SM; Eldred-Evans D; Wulaningsih W; Popert R; Wolfe K; Van Hemelrijck M; Rottenberg G; Liyanage SH; Acher P
Int Urol Nephrol; 2017 Aug; 49(8):1335-1342. PubMed ID: 28477301
[TBL] [Abstract][Full Text] [Related]
6. PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5-10.0 ng ml (-1) and 10.1-20.0 ng ml (-1) : a multicenter study.
Lin YR; Wei XH; Uhlman M; Lin XT; Wu SF; Diao PF; Xie HQ; Xie KJ; Tang P
Asian J Androl; 2015; 17(3):503-7. PubMed ID: 25475661
[TBL] [Abstract][Full Text] [Related]
7. Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men.
Sheikh M; Al-Saeed O; Kehinde EO; Sinan T; Anim JT; Ali Y
Int Urol Nephrol; 2005; 37(4):721-6. PubMed ID: 16362587
[TBL] [Abstract][Full Text] [Related]
8. Utility of the transition zone index for identification of prostate cancer in Chinese men with intermediate PSA levels.
Qi TY; Chen YQ; Jiang J; Zhu YK; Yao XH; Wang XJ
Int Urol Nephrol; 2012 Jun; 44(3):807-15. PubMed ID: 22311386
[TBL] [Abstract][Full Text] [Related]
9. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
[TBL] [Abstract][Full Text] [Related]
10. The use of prostate specific antigen (PSA) density in detecting prostate cancer in Chinese men with PSA levels of 4-10 ng/mL.
Zheng XY; Xie LP; Wang YY; Ding W; Yang K; Shen HF; Qin J; Bai Y; Chen ZD
J Cancer Res Clin Oncol; 2008 Nov; 134(11):1207-10. PubMed ID: 18446367
[TBL] [Abstract][Full Text] [Related]
11. Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml
Wang C; Wang YY; Wang SY; Ding JX; Ding M; Ruan Y; Wang XH; Jing YF; Han BM; Xia SJ; Jiang CY; Zhao FJ
Asian J Androl; 2021; 23(4):415-420. PubMed ID: 33473011
[TBL] [Abstract][Full Text] [Related]
12. Significant Diagnostic Value of Free-Serum PSA (FPSA)/Prostate-Specific Antigen Density (PSAD) and (F/T)/PSAD for Prostate Cancer of the Chinese Population in a Single Institution.
Nan LB; Yin XT; Gao JP
Med Sci Monit; 2019 Nov; 25():8345-8351. PubMed ID: 31691648
[TBL] [Abstract][Full Text] [Related]
13. Is PSA density of the peripheral zone as a useful predictor for prostate cancer in patients with gray zone PSA levels?
Lee J; Yang SW; Jin L; Lee CL; Lee JY; Shin JH; Lim JS; Song KH
BMC Cancer; 2021 Apr; 21(1):472. PubMed ID: 33910525
[TBL] [Abstract][Full Text] [Related]
14. [Retrospective evaluation of PSA density for selection of biopsy candidates with prostate specific antigen in the gray zone].
Tochigi T; Kawamura S; Numahata K; Tokuyama S; Kuwahara M; Horaguchi T; Satou S
Nihon Hinyokika Gakkai Zasshi; 2001 Sep; 92(6):609-14. PubMed ID: 11593702
[TBL] [Abstract][Full Text] [Related]
15. Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml.
Chang TH; Lin WR; Tsai WK; Chiang PK; Chen M; Tseng JS; Chiu AW
BMC Urol; 2020 Oct; 20(1):151. PubMed ID: 33028274
[TBL] [Abstract][Full Text] [Related]
16. [Utility of prostate specific antigen (PSA) density in detecting prostate cancer in men showing gray zone serum PSA levels].
Kihara T; Ito F; Kobayashi C; Ryoji O; Tokumoto T; Iguchi Y; Maeda Y; Onizuka S; Goya N; Nakazawa H; Toma H
Hinyokika Kiyo; 1997 Jan; 43(1):13-8. PubMed ID: 9046415
[TBL] [Abstract][Full Text] [Related]
17. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml].
Janane A; Hajji F; Ismail T; Jawad C; Elondo JC; Dakka Y; Ghadouane M; Ameur A; Abbar M; Albouzidi A
Actas Urol Esp; 2012 Feb; 36(2):93-8. PubMed ID: 22188752
[TBL] [Abstract][Full Text] [Related]
19. [Value of prostate-specific antigen density and transitional-zone prostate-specific antigen density in the diagnosis of prostate cancer].
Martínez Jabaloyas JM; García Morata F; Villamón Fort R; Pastor Hernández F; Gil Salom M; García Sisamón F
Actas Urol Esp; 2003 Jun; 27(6):442-9. PubMed ID: 12918151
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY
Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]